Introduction
The rapid adoption of connected medical devices such as infusion pumps has transformed patient care across hospitals in Malaysia. These devices deliver precise doses of medication, fluids, and nutrients, making them critical to patient safety. However, as infusion pumps become integrated with hospital networks, cloud systems, and IoMT ecosystems, they also become vulnerable to cybersecurity threats.
Regulatory frameworks such as the EU MDR and FDA 510(k) now emphasize cybersecurity as a core safety requirement, not just a technical feature. For manufacturers targeting global markets while operating in Malaysia, aligning security testing with these frameworks is essential to ensure regulatory approval, patient safety, and market trust.
EU MDR & FDA 510(k) Cybersecurity Requirements
Security testing for infusion pumps in Malaysia must be aligned with EU MDR (Regulation (EU) 2017/745) and based on FDA 510(k) cybersecurity expectations.
EU MDR (European Union)
EU MDR requires manufacturers to ensure that medical devices are designed and maintained with state-of-the-art cybersecurity controls to protect patient data and device functionality. The regulation emphasizes:
Risk management throughout the device lifecycle
Protection against unauthorized access
Secure software development and validation
Post-market surveillance and vulnerability management
FDA 510(k) (United States)
The FDA mandates that cybersecurity be demonstrated as part of device safety and effectiveness. For infusion pumps and similar connected devices:
Cybersecurity must be integrated into premarket submissions
Manufacturers must provide threat models, SBOM, and risk analysis
Devices must include controls like authentication, encryption, and secure updates
Lifecycle risk management and incident response are required
The FDA explicitly recognizes that cybersecurity failures in devices like infusion pumps can lead to therapy disruption, unauthorized control, and patient harm
Malaysia Context
While Malaysia follows local regulatory oversight through the Medical Device Authority (MDA), global manufacturers must align with EU MDR and FDA standards to:
Enable international market access
Meet hospital procurement requirements
Ensure cross-border compliance
Importance of Security Testing for Infusion Pumps
Infusion pumps are among the most sensitive medical devices due to their direct impact on patient treatment. Cybersecurity vulnerabilities in these devices can have life-threatening consequences.
Key Risks
Unauthorized Device Control
Attackers could alter dosage levels or stop therapy deliveryData Manipulation & Leakage
Patient health data transmitted by pumps can be interceptedNetwork Exploitation
Infusion pumps connected to hospital networks can serve as entry pointsRansomware Impact
Devices can be locked or disabled during critical care
The FDA has highlighted real-world vulnerabilities in infusion systems, where attackers could remotely access or modify device settings if not secured properly
Why Security Testing is Critical
Ensures patient safety and treatment accuracy
Supports EU MDR conformity assessment
Enables FDA 510(k) clearance
Reduces risk of recalls and regulatory penalties
Strengthens trust with healthcare providers
Our Methodology – Infusion Pump Security Testing Methodology
Cyberintelsys follows a structured and compliance-driven methodology aligned with EU MDR and FDA 510(k) cybersecurity expectations.
1. Device Risk & Threat Modeling
Identification of critical assets (software, firmware, data flows)
Threat modeling based on real-world attack scenarios
Mapping risks to patient safety impact
2. Architecture & Design Review
Evaluation of secure design principles
Assessment of authentication and authorization mechanisms
Verification of encryption protocols
3. Vulnerability Assessment
Static and dynamic analysis of device software
Identification of known vulnerabilities (CVEs)
Assessment of third-party components and libraries
4. Penetration Testing
Simulated real-world attacks on infusion pump systems
Testing network interfaces, APIs, and wireless communication
Validation of exploitability and risk severity
5. Firmware & Embedded Security Testing
Secure boot validation
Firmware integrity and update mechanism testing
Reverse engineering resistance checks
6. Communication Security Testing
Evaluation of data transmission security (TLS, encryption)
Testing for man-in-the-middle (MITM) attacks
Wireless protocol security validation
7. SBOM & Compliance Validation
Software Bill of Materials (SBOM) analysis
Verification of open-source risks
Alignment with FDA documentation requirements
8. Post-Market Security Readiness
Incident response plan validation
Patch management and update mechanisms
Continuous monitoring strategy
Cyberintelsys Services for Infusion Pump Security
Cyberintelsys delivers specialized security testing services tailored for infusion pumps and connected medical devices.
1. Vulnerability Assessment (VA)
Identification of weaknesses in device software and infrastructure
CVE-based risk analysis
Prioritized remediation guidance
2. Penetration Testing (PT)
Ethical hacking simulations targeting infusion pump environments
Network, firmware, and application-level attacks
Exploit validation and reporting
3. Threat Modeling & Risk Assessment
Comprehensive risk analysis aligned with ISO 14971
Mapping cybersecurity risks to patient safety
Regulatory-ready documentation
4. Secure Code Review
Static code analysis for vulnerabilities
Identification of insecure coding practices
Recommendations for secure development
5. SBOM Analysis & Validation
Identification of third-party and open-source components
Vulnerability tracking and risk mitigation
FDA 510(k) documentation support
6. Regulatory Compliance Support
EU MDR cybersecurity alignment
FDA 510(k) submission support
Documentation preparation and gap analysis
7. IoMT & Network Security Testing
Testing infusion pumps within hospital ecosystems
Network segmentation validation
Lateral movement risk assessment
Why Choose Cyberintelsys
Cyberintelsys stands out as a trusted cybersecurity partner for medical device manufacturers in Malaysia and globally.
Cyberintelsys is a CREST-accredited cybersecurity company for Vulnerability Assessment (VA) and Penetration Testing (PT), delivering industry-recognized security testing services for organizations across multiple sectors.
Deep expertise in medical device cybersecurity and IoMT ecosystems
Strong alignment with EU MDR and FDA 510(k) cybersecurity expectations
Proven methodologies for infusion pump and critical device testing
Focus on patient safety and regulatory success
End-to-end support from risk assessment to compliance documentation
Contact Cyberintelsys
As infusion pumps continue to evolve with advanced connectivity and digital capabilities, ensuring robust cybersecurity is no longer optional it is a regulatory and clinical necessity.
Cyberintelsys helps organizations in Malaysia and global markets:
Strengthen infusion pump security
Achieve EU MDR and FDA 510(k) compliance
Protect patients and healthcare infrastructure
Get in touch with Cyberintelsys today to secure your medical devices and accelerate regulatory approval with confidence.
